| The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats. | |
MedLine Citation:
|
PMID: 36458 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Disagreement in the literature about the occurrence of rebound hypertension (hypertensive overshoot) in animal models initiated this investigation. Oral doses of clonidine (0.03 mg kg-1) or guanfacine (0.3 mg kg-1) were administered twice daily during three weeks to groups of normotensive and renal hypertensive rats. Blood pressure and heart rate were measured immediately before and 3 h after the first daily dose, and compared with values obtained from placebo-treated control rats. Treatment with either drug induced large daily fluctuations rather than sustained falls in blood pressure. In the normotensive, but not in the hypertensive groups, the morning blood pressures measured before the first daily dose were significantly elevated over those of the control groups after 9 and 5 days of treatment with clonidine or guanfacine. This elevation persisted for 3 days after drug withdrawal. It is concluded that in the rat the duration of action of both drugs was short, so that twice daily administration of both drugs similarly produced large daily fluctuations rather than sustained falls in blood pressure. Blood pressure rises developed during treatment rather than after withdrawal in normotensive rats only. Therefore, this type of study does not relate well to the human situation and different experimental approaches to this problem are needed. |
Authors:
|
R Salzmann |
Related Documents
:
|
6385278 - Comparative antihypertensive and endocrinologic effects of clonidine and prazosin in pa... 7379338 - Profile of a new prazosin congener, bl-5111a. studies in the rat. 18468998 - Blood pressure is regulated by an alpha1d-adrenergic receptor/dystrophin signalosome. 7380588 - Effect of clonidine on excitability and refractoriness of normal cat myocardium. 25018898 - The lingering dilemma of arterial pressure in ckd: what do we know, where do we go? 2263398 - Respiratory function during oxygen administration in chronic obstructive pulmonary dise... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of pharmacy and pharmacology Volume: 31 ISSN: 0022-3573 ISO Abbreviation: J. Pharm. Pharmacol. Publication Date: 1979 Apr |
Date Detail:
|
Created Date: 1979-09-01 Completed Date: 1979-09-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0376363 Medline TA: J Pharm Pharmacol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 212-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antihypertensive Agents / pharmacology*, therapeutic use Blood Pressure / drug effects* Clonidine / pharmacology*, therapeutic use Female Guanidines / pharmacology*, therapeutic use Heart Rate / drug effects* Humans Hypertension, Renal / drug therapy, physiopathology* Phenylacetates / pharmacology*, therapeutic use Rats Substance Withdrawal Syndrome / physiopathology* Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Guanidines; 0/Phenylacetates; 4205-90-7/Clonidine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates c...
Next Document: Characterization of receptors on postganglionic cholinergic neurons in the guinea-pig isolated ileum...